DM, CV Disease and Lipid Management in Patients Who Are High Risk

New ACC vs AACE’s Lipid Guidelines – Impact on CVD

Wednesday, April 24
8:35 AM - 9:00 AM
Location: Convention Center 502 B

Learning Objectives:

Paul S. Jellinger, MD, MACE

Professor of Clinical Medicine
University of Miami / The Center for Diabetes & Endocrine Care, Hollywood FL

Paul Jellinger, MD, MACE is a Professor of Clinical Medicine on the Voluntary Faculty at the University of Miami Miller School of Medicine and practices clinical endocrinology at The Center for Diabetes & Endocrine Care in Hollywood, Florida. He is a past president of AACE and the American College of Endocrinology and a Master of the American College of Endocrinology. He has been very active in the production of AACE Diabetes and Lipid Guidelines since their origin co-chairing the first AACE Diabetes Algorithm. He was Chair of the Writing Committee for the comprehensive 2017 AACE/ACE lipid clinical practice guidelines for "Management of Dyslipidemia and Preventioin of Cardiovascular Disease". He has participated as a Task Force member in numerous AACE Consensus Conferences and Position Statements and has more than 40 publications.

Presentation(s):

Send Email for Paul Jellinger


Assets

New ACC vs AACE’s Lipid Guidelines – Impact on CVD

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for New ACC vs AACE’s Lipid Guidelines – Impact on CVD